Google+ Facebook Twitter Twitter

New monotest system launched

Launch Diagnostics is pleased to introduce the new VIrClia monotest system, an indirect chemiluminescent immunoassay for the detection of antibodies against infectious diseases in human serum or plasma samples.

Each monotest contains wells for automatic sample addition plus the reagents necessary to perform the assay.  

Assays are automatically processed on the VirClia instrument with VirClia processing and interpretation software. 

The easy-to-use system supports bar code identification, use of primary sample tubes within the instrument racks and is completely versatile, enabling the custom set up of different assays in a single run. The Vircell portfolio includes infectious disease ELISAs and IFAs.

Related Articles

Microwave iStock

Antibiotic resistance and microwaves

Lecturer in Molecular Microbiology Tina Joshi looks at the detection of antimicrobial-resistant bacteria in the timeframe of a doctor’s appointment.

New delivery method for immunotherapy combination

Using nanoparticles to bind molecules that can unleash and stimulate immune cells, US researchers found they could more effectively trigger the body’s defence systems against cancer in laboratory studies.

“One-stop shops to speed up diagnosis”

"One-stop shop to speed up cancer diagnosis"

Special centres that are aimed at speeding up cancer diagnosis are being introduced across Englan